BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8460709)

  • 1. Control of gastric corpus chromogranin A messenger RNA abundance in the rat.
    Dimaline R; Evans D; Forster ER; Sandvik AK; Dockray GJ
    Am J Physiol; 1993 Mar; 264(3 Pt 1):G583-8. PubMed ID: 8460709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of enterochromaffin-like cell histamine increases histidine decarboxylase and chromogranin A mRNA levels in rat stomach by a gastrin-independent mechanism.
    Andersson K; Lindström E; Chen D; Monstein HJ; Boketoft A; Håkanson R
    Scand J Gastroenterol; 1996 Oct; 31(10):959-65. PubMed ID: 8898415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ; Lindström E; Håkanson R
    Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gastrin receptor blockade on gastrin and histidine decarboxylase gene expression in rats during achlorhydria.
    Simon B; Eissele R; Czornik M; Swarovsky B; Arnold R
    Scand J Gastroenterol; 1995 Jun; 30(6):503-10. PubMed ID: 7569754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the chromogranin A-derived peptides pancreastatin and WE14 in rat stomach ECL cells.
    Norlén P; Curry WJ; Chen D; Zhao CM; Johnston CF; Håkanson R
    Regul Pept; 1997 Jun; 70(2-3):121-33. PubMed ID: 9272624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of tissue progastrin concentrations in the rat.
    Varro A; Yegen B; Dockray GJ
    Exp Physiol; 1993 May; 78(3):327-36. PubMed ID: 8329207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional impairment of the individual rat stomach ECL cell in response to sustained hypergastrinemia.
    Kimura K; Chen D; Lindström E; Yamada H; Zhao CM; Håkanson R
    Regul Pept; 1997 Oct; 72(2-3):69-77. PubMed ID: 9652979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
    Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
    Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional control of chromogranin A and B concentrations in the body of the rat stomach.
    Watkinson A; Dockray GJ
    Regul Pept; 1992 Jul; 40(1):51-61. PubMed ID: 1438976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of nicotine and a H2-receptor antagonist, famotidine, on gastrin and chromogranin A expression.
    Gomez G; Udupi V; Greeley GH
    Regul Pept; 1997 Mar; 69(2):77-82. PubMed ID: 9178349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by omeprazole of the depression of gastrin cell function by fasting in the rat.
    Dimaline R; Evans D; Varro A; Dockray GJ
    J Physiol; 1991 Feb; 433():483-93. PubMed ID: 1841954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice.
    Höcker M; Cramer T; O'Connor DT; Rosewicz S; Wiedenmann B; Wang TC
    Gastroenterology; 2001 Jul; 121(1):43-55. PubMed ID: 11438493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
    Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
    Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin cell responses to acidification of the achlorhydric rat stomach.
    Dockray GJ; Dimaline R; Forster ER; Evans D; Sandvik A; Varro A
    Am J Physiol; 1993 Sep; 265(3 Pt 1):G440-4. PubMed ID: 8214065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of a vesicular monoamine transporter in rat stomach: a putative histamine transporter.
    Dimaline R; Struthers J
    J Physiol; 1996 Jan; 490 ( Pt 1)(Pt 1):249-56. PubMed ID: 8745292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of food intake by omeprazole in the chicken.
    Campbell BJ; Dimaline R; Dockray GJ; Hughes J
    Eur J Pharmacol; 1991 Dec; 209(3):231-5. PubMed ID: 1797564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food stimulation of histidine decarboxylase messenger RNA abundance in rat gastric fundus.
    Dimaline R; Sandvik AK; Evans D; Forster ER; Dockray GJ
    J Physiol; 1993 Jun; 465():449-58. PubMed ID: 8229845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.